Concepedia
Statistics
Publications
4
Citations
84
H-Index
Active since
2016
Affiliations
Gilead Sciences (United States)(Current)
Center for Cancer Research
Stanford University
Sarah Cannon
University of Alabama at Birmingham
Yanan Huo is an author at Gilead Sciences (United States) specializing in oncology, immunotherapy safety, and cancer pharmacology.
Publications per year
2016–2025
Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial
Amitkumar Mehta, Leslie Popplewell, Graham P. Collins et al. · Blood Advances · 2024 · 26 citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17
Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma
Joeseph Maakaron, Adam S. Asch, Leslie Popplewell et al. · Blood Advances · 2024 · 21 citations · Full text
Medicine, Oncology, Pharmacotherapy +17
A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors
Cathy Eng, Nehal J. Lakhani, Philip A. Philip et al. · Targeted Oncology · 2025 · 20 citations · Full text
Medicine, Oncology, Pharmacology +17
TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53
Yinxiang Lv, Yanan Huo, Xi-Can Yu et al. · Drug Design Development and Therapy · 2016 · 17 citations · Full text
Medicine, Oncology, Pharmacology +13
1–4 of 4